Rochester, NY, United States of America

Frederick A Klipstein

This inventor holds 1 USPTO granted patent. Top assignee: University of Rochester. Active years: 1983.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Frederick A. Klipstein

Introduction

Frederick A. Klipstein is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of immunology, particularly in developing novel immunogens. His work is recognized for its potential impact on public health, especially in combating diarrheal diseases.

Latest Patents

Frederick A. Klipstein holds a patent for a composition of a novel immunogen aimed at providing protection against diarrheal diseases. This patent showcases his innovative approach to addressing critical health issues through scientific research. He has 1 patent to his name, reflecting his commitment to advancing medical science.

Career Highlights

Klipstein is affiliated with the University of Rochester, where he conducts research and collaborates with other experts in the field. His work at the university has allowed him to explore various aspects of immunology and contribute to the academic community. His dedication to research has positioned him as a valuable asset in the scientific community.

Collaborations

One of his notable collaborators is Richard E. Engert. Together, they have worked on projects that aim to enhance the understanding of immunological responses and develop effective solutions for health challenges.

Conclusion

Frederick A. Klipstein's contributions to immunology through his innovative patent and collaborative efforts at the University of Rochester highlight his role as a significant figure in the field. His work continues to inspire advancements in medical research and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…